Work

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-139445

Authors: Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aravind Ramakrishnan, David Eiznhamer, Olivier Schueller, Zhongming Yang, Laurie S. Green, Sanjay K. Aggarwal, Bruce R. Blazar, Steven Z. Pavletic, Madan Jagasia

Institutions: Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Stanford University, Colorado Blood Cancer Institute, St David's Medical Center, Kadmon Corporation (United States), University of Minnesota, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Vanderbilt University Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4230064049

FWCI: 1.498

Cites:

Cited by: 14

Related to: 10